APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immunoprecipitation (IP) Kit

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Immunoprecipitation (IP) Kit Market Outlook and Growth Opportunities 2026

22 December 2025207 pages

Choose your research edition.

Industry ResearchImmunoprecipitation (IP) Kit Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Immunoprecipitation (IP) Kit Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Immunoprecipitation (IP) Kit Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immunoprecipitation (IP) Kit Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Immunoprecipitation (IP) Kit Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Immunoprecipitation (IP) Kit market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Immunoprecipitation (IP) Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Immunoprecipitation (IP) Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immunoprecipitation (IP) Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Immunoprecipitation (IP) Kit market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Immunoprecipitation (IP) Kit market include Abbkine Scientific Co., Ltd., Active Motif, CD Bioparticles, Cell Signaling Technology, Inc., Engibody Biotechnology, Inc., MyBiosource, Inc., Novus Biologicals, Proteintech Group, Inc. and Rockland Immunochemicals, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Immunoprecipitation (IP) Kit market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Immunoprecipitation (IP) Kit and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Immunoprecipitation (IP) Kit sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Immunoprecipitation (IP) Kit market size, projected growth trends, production technologies, key applications, and end-use industries.

Immunoprecipitation (IP) Kit Segment by Company

Abbkine Scientific Co., Ltd.

Active Motif

CD Bioparticles

Cell Signaling Technology, Inc.

Engibody Biotechnology, Inc.

MyBiosource, Inc.

Novus Biologicals

Proteintech Group, Inc.

Rockland Immunochemicals, Inc.

Sino Biological, Inc.

Takara Bio Inc.

Merck KGaA

ACE Biotechnology

Thermo Fisher Scientific (China) Co., Ltd.

Beyotime Biotech. Inc.

Shanghai Epizyme Biomedical Technology Co., Ltd

Beaver

Wuhan Dia-An Biotechnology Co., Ltd

Immunoprecipitation (IP) Kit Segment by Type

Protein A

Protein G

Immunoprecipitation (IP) Kit Segment by Application

Pharmaceuticals and Biotechnology

Hospital and Diagnostic Laboratory

Research Institute

Other

Immunoprecipitation (IP) Kit Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Immunoprecipitation (IP) Kit status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Immunoprecipitation (IP) Kit market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Immunoprecipitation (IP) Kit significant trends, drivers, influence factors in global and regions.

6. To analyze Immunoprecipitation (IP) Kit competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunoprecipitation (IP) Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immunoprecipitation (IP) Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunoprecipitation (IP) Kit.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Immunoprecipitation (IP) Kit market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Immunoprecipitation (IP) Kit industry.

Chapter 3: Detailed analysis of Immunoprecipitation (IP) Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Immunoprecipitation (IP) Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Immunoprecipitation (IP) Kit in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Immunoprecipitation (IP) Kit Industry Trends Table 2. Immunoprecipitation (IP) Kit Industry Drivers Table 3. Immunoprecipitation (IP) Kit Industry Opportunities and Challenges Table 4. Immunoprecipitation (IP) Kit Industry Restraints Table 5. Global Immunoprecipitation (IP) Kit Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Immunoprecipitation (IP) Kit Revenue Share by Company (2021-2026) Table 7. Global Immunoprecipitation (IP) Kit Sales Volume by Company (k units) & (2021-2026) Table 8. Global Immunoprecipitation (IP) Kit Sales Volume Share by Company (2021-2026) Table 9. Global Immunoprecipitation (IP) Kit Average Price (US$/unit) of Company (2021-2026) Table 10. Global Immunoprecipitation (IP) Kit Company Ranking, (2024-2026) & (USD Million) Table 11. Global Immunoprecipitation (IP) Kit Key Company Manufacturing Base & Headquarters Table 12. Global Immunoprecipitation (IP) Kit Company, Product Type & Application Table 13. Global Immunoprecipitation (IP) Kit Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Immunoprecipitation (IP) Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Protein A Table 18. Significant Companies of Protein G Table 19. Global Immunoprecipitation (IP) Kit Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Immunoprecipitation (IP) Kit Sales Volume by Type (2021-2026) & (k units) Table 21. Global Immunoprecipitation (IP) Kit Sales Volume by Type (2027-2032) & (k units) Table 22. Global Immunoprecipitation (IP) Kit Sales Volume Share by Type (2021-2026) Table 23. Global Immunoprecipitation (IP) Kit Sales Volume Share by Type (2027-2032) Table 24. Global Immunoprecipitation (IP) Kit Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Immunoprecipitation (IP) Kit Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Immunoprecipitation (IP) Kit Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Immunoprecipitation (IP) Kit Sales Value Share by Type (2021-2026) Table 28. Global Immunoprecipitation (IP) Kit Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Pharmaceuticals and Biotechnology Table 30. Significant Companies of Hospital and Diagnostic Laboratory Table 31. Significant Companies of Research Institute Table 32. Significant Companies of Other Table 33. Global Immunoprecipitation (IP) Kit Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Immunoprecipitation (IP) Kit Sales Volume by Application (2021-2026) & (k units) Table 35. Global Immunoprecipitation (IP) Kit Sales Volume by Application (2027-2032) & (k units) Table 36. Global Immunoprecipitation (IP) Kit Sales Volume Share by Application (2021-2026) Table 37. Global Immunoprecipitation (IP) Kit Sales Volume Share by Application (2027-2032) Table 38. Global Immunoprecipitation (IP) Kit Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Immunoprecipitation (IP) Kit Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Immunoprecipitation (IP) Kit Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Immunoprecipitation (IP) Kit Sales Value Share by Application (2021-2026) Table 42. Global Immunoprecipitation (IP) Kit Sales Value Share by Application (2027-2032) Table 43. Global Immunoprecipitation (IP) Kit Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Immunoprecipitation (IP) Kit Sales by Region (2021-2026) & (k units) Table 45. Global Immunoprecipitation (IP) Kit Sales Market Share by Region (2021-2026) Table 46. Global Immunoprecipitation (IP) Kit Sales by Region (2027-2032) & (k units) Table 47. Global Immunoprecipitation (IP) Kit Sales Market Share by Region (2027-2032) Table 48. Global Immunoprecipitation (IP) Kit Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Immunoprecipitation (IP) Kit Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Immunoprecipitation (IP) Kit Sales Value Share by Region (2021-2026) Table 51. Global Immunoprecipitation (IP) Kit Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Immunoprecipitation (IP) Kit Sales Value Share by Region (2027-2032) Table 53. Global Immunoprecipitation (IP) Kit Market Average Price (US$/unit) by Region (2021-2026) Table 54. Global Immunoprecipitation (IP) Kit Market Average Price (US$/unit) by Region (2027-2032) Table 55. Global Immunoprecipitation (IP) Kit Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Immunoprecipitation (IP) Kit Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Immunoprecipitation (IP) Kit Sales by Country (2021-2026) & (k units) Table 58. Global Immunoprecipitation (IP) Kit Sales Market Share by Country (2021-2026) Table 59. Global Immunoprecipitation (IP) Kit Sales by Country (2027-2032) & (k units) Table 60. Global Immunoprecipitation (IP) Kit Sales Market Share by Country (2027-2032) Table 61. Global Immunoprecipitation (IP) Kit Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Immunoprecipitation (IP) Kit Sales Value Market Share by Country (2021-2026) Table 63. Global Immunoprecipitation (IP) Kit Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Immunoprecipitation (IP) Kit Sales Value Market Share by Country (2027-2032) Table 65. Abbkine Scientific Co., Ltd. Company Information Table 66. Abbkine Scientific Co., Ltd. Business Overview Table 67. Abbkine Scientific Co., Ltd. Immunoprecipitation (IP) Kit Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Abbkine Scientific Co., Ltd. Immunoprecipitation (IP) Kit Product Portfolio Table 69. Abbkine Scientific Co., Ltd. Recent Development Table 70. Active Motif Company Information Table 71. Active Motif Business Overview Table 72. Active Motif Immunoprecipitation (IP) Kit Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Active Motif Immunoprecipitation (IP) Kit Product Portfolio Table 74. Active Motif Recent Development Table 75. CD Bioparticles Company Information Table 76. CD Bioparticles Business Overview Table 77. CD Bioparticles Immunoprecipitation (IP) Kit Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. CD Bioparticles Immunoprecipitation (IP) Kit Product Portfolio Table 79. CD Bioparticles Recent Development Table 80. Cell Signaling Technology, Inc. Company Information Table 81. Cell Signaling Technology, Inc. Business Overview Table 82. Cell Signaling Technology, Inc. Immunoprecipitation (IP) Kit Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Cell Signaling Technology, Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 84. Cell Signaling Technology, Inc. Recent Development Table 85. Engibody Biotechnology, Inc. Company Information Table 86. Engibody Biotechnology, Inc. Business Overview Table 87. Engibody Biotechnology, Inc. Immunoprecipitation (IP) Kit Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Engibody Biotechnology, Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 89. Engibody Biotechnology, Inc. Recent Development Table 90. MyBiosource, Inc. Company Information Table 91. MyBiosource, Inc. Business Overview Table 92. MyBiosource, Inc. Immunoprecipitation (IP) Kit Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. MyBiosource, Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 94. MyBiosource, Inc. Recent Development Table 95. Novus Biologicals Company Information Table 96. Novus Biologicals Business Overview Table 97. Novus Biologicals Immunoprecipitation (IP) Kit Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Novus Biologicals Immunoprecipitation (IP) Kit Product Portfolio Table 99. Novus Biologicals Recent Development Table 100. Proteintech Group, Inc. Company Information Table 101. Proteintech Group, Inc. Business Overview Table 102. Proteintech Group, Inc. Immunoprecipitation (IP) Kit Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Proteintech Group, Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 104. Proteintech Group, Inc. Recent Development Table 105. Rockland Immunochemicals, Inc. Company Information Table 106. Rockland Immunochemicals, Inc. Business Overview Table 107. Rockland Immunochemicals, Inc. Immunoprecipitation (IP) Kit Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Rockland Immunochemicals, Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 109. Rockland Immunochemicals, Inc. Recent Development Table 110. Sino Biological, Inc. Company Information Table 111. Sino Biological, Inc. Business Overview Table 112. Sino Biological, Inc. Immunoprecipitation (IP) Kit Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Sino Biological, Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 114. Sino Biological, Inc. Recent Development Table 115. Takara Bio Inc. Company Information Table 116. Takara Bio Inc. Business Overview Table 117. Takara Bio Inc. Immunoprecipitation (IP) Kit Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Takara Bio Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 119. Takara Bio Inc. Recent Development Table 120. Merck KGaA Company Information Table 121. Merck KGaA Business Overview Table 122. Merck KGaA Immunoprecipitation (IP) Kit Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Merck KGaA Immunoprecipitation (IP) Kit Product Portfolio Table 124. Merck KGaA Recent Development Table 125. ACE Biotechnology Company Information Table 126. ACE Biotechnology Business Overview Table 127. ACE Biotechnology Immunoprecipitation (IP) Kit Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. ACE Biotechnology Immunoprecipitation (IP) Kit Product Portfolio Table 129. ACE Biotechnology Recent Development Table 130. Thermo Fisher Scientific (China) Co., Ltd. Company Information Table 131. Thermo Fisher Scientific (China) Co., Ltd. Business Overview Table 132. Thermo Fisher Scientific (China) Co., Ltd. Immunoprecipitation (IP) Kit Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 133. Thermo Fisher Scientific (China) Co., Ltd. Immunoprecipitation (IP) Kit Product Portfolio Table 134. Thermo Fisher Scientific (China) Co., Ltd. Recent Development Table 135. Beyotime Biotech. Inc. Company Information Table 136. Beyotime Biotech. Inc. Business Overview Table 137. Beyotime Biotech. Inc. Immunoprecipitation (IP) Kit Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 138. Beyotime Biotech. Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 139. Beyotime Biotech. Inc. Recent Development Table 140. Shanghai Epizyme Biomedical Technology Co., Ltd Company Information Table 141. Shanghai Epizyme Biomedical Technology Co., Ltd Business Overview Table 142. Shanghai Epizyme Biomedical Technology Co., Ltd Immunoprecipitation (IP) Kit Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 143. Shanghai Epizyme Biomedical Technology Co., Ltd Immunoprecipitation (IP) Kit Product Portfolio Table 144. Shanghai Epizyme Biomedical Technology Co., Ltd Recent Development Table 145. Beaver Company Information Table 146. Beaver Business Overview Table 147. Beaver Immunoprecipitation (IP) Kit Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 148. Beaver Immunoprecipitation (IP) Kit Product Portfolio Table 149. Beaver Recent Development Table 150. Wuhan Dia-An Biotechnology Co., Ltd Company Information Table 151. Wuhan Dia-An Biotechnology Co., Ltd Business Overview Table 152. Wuhan Dia-An Biotechnology Co., Ltd Immunoprecipitation (IP) Kit Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 153. Wuhan Dia-An Biotechnology Co., Ltd Immunoprecipitation (IP) Kit Product Portfolio Table 154. Wuhan Dia-An Biotechnology Co., Ltd Recent Development Table 155. Key Raw Materials Table 156. Raw Materials Key Suppliers Table 157. Immunoprecipitation (IP) Kit Distributors List Table 158. Immunoprecipitation (IP) Kit Customers List Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Immunoprecipitation (IP) Kit Product Image Figure 2. Global Immunoprecipitation (IP) Kit Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immunoprecipitation (IP) Kit Sales Value (2021-2032) & (US$ Million) Figure 4. Global Immunoprecipitation (IP) Kit Sales (2021-2032) & (k units) Figure 5. Global Immunoprecipitation (IP) Kit Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Immunoprecipitation (IP) Kit Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Protein A Image Figure 10. Protein G Image Figure 11. Global Immunoprecipitation (IP) Kit Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Immunoprecipitation (IP) Kit Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Immunoprecipitation (IP) Kit Sales Volume Share by Type (2021-2032) Figure 14. Global Immunoprecipitation (IP) Kit Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Immunoprecipitation (IP) Kit Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Immunoprecipitation (IP) Kit Sales Value Share by Type (2021-2032) Figure 17. Pharmaceuticals and Biotechnology Image Figure 18. Hospital and Diagnostic Laboratory Image Figure 19. Research Institute Image Figure 20. Other Image Figure 21. Global Immunoprecipitation (IP) Kit Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Immunoprecipitation (IP) Kit Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Immunoprecipitation (IP) Kit Sales Volume Share by Application (2021-2032) Figure 24. Global Immunoprecipitation (IP) Kit Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Immunoprecipitation (IP) Kit Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Immunoprecipitation (IP) Kit Sales Value Share by Application (2021-2032) Figure 27. Global Immunoprecipitation (IP) Kit Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Immunoprecipitation (IP) Kit Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Immunoprecipitation (IP) Kit Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Immunoprecipitation (IP) Kit Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Immunoprecipitation (IP) Kit Sales Value (2021-2032) & (US$ Million) Figure 32. North America Immunoprecipitation (IP) Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Immunoprecipitation (IP) Kit Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Immunoprecipitation (IP) Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Immunoprecipitation (IP) Kit Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Immunoprecipitation (IP) Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Immunoprecipitation (IP) Kit Sales Value (2021-2032) & (US$ Million) Figure 38. South America Immunoprecipitation (IP) Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Immunoprecipitation (IP) Kit Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Immunoprecipitation (IP) Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Immunoprecipitation (IP) Kit Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Immunoprecipitation (IP) Kit Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Protein A
  • Protein G
Applications
  • Pharmaceuticals and Biotechnology
  • Hospital and Diagnostic Laboratory
  • Research Institute
  • Other
Companies covered
  • Abbkine Scientific Co., Ltd.
  • Active Motif
  • CD Bioparticles
  • Cell Signaling Technology, Inc.
  • Engibody Biotechnology, Inc.
  • MyBiosource, Inc.
  • Novus Biologicals
  • Proteintech Group, Inc.
  • Rockland Immunochemicals, Inc.
  • Sino Biological, Inc.
  • Takara Bio Inc.
  • Merck KGaA
  • ACE Biotechnology
  • Thermo Fisher Scientific (China) Co., Ltd.
  • Beyotime Biotech. Inc.
  • Shanghai Epizyme Biomedical Technology Co., Ltd
  • Beaver
  • Wuhan Dia-An Biotechnology Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Immunoprecipitation (IP) Kit Sales Value (2021-2032)
  4. 1.2.2 Global Immunoprecipitation (IP) Kit Sales Volume (2021-2032)
  5. 1.2.3 Global Immunoprecipitation (IP) Kit Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Immunoprecipitation (IP) Kit Market Dynamics
  1. 2.1 Immunoprecipitation (IP) Kit Industry Trends
  2. 2.2 Immunoprecipitation (IP) Kit Industry Drivers
  3. 2.3 Immunoprecipitation (IP) Kit Industry Opportunities and Challenges
  4. 2.4 Immunoprecipitation (IP) Kit Industry Restraints
3 Immunoprecipitation (IP) Kit Market by Company
  1. 3.1 Global Immunoprecipitation (IP) Kit Company Revenue Ranking in 2025
  2. 3.2 Global Immunoprecipitation (IP) Kit Revenue by Company (2021-2026)
  3. 3.3 Global Immunoprecipitation (IP) Kit Sales Volume by Company (2021-2026)
  4. 3.4 Global Immunoprecipitation (IP) Kit Average Price by Company (2021-2026)
  5. 3.5 Global Immunoprecipitation (IP) Kit Company Ranking (2024-2026)
  6. 3.6 Global Immunoprecipitation (IP) Kit Company Manufacturing Base and Headquarters
  7. 3.7 Global Immunoprecipitation (IP) Kit Company Product Type and Application
  8. 3.8 Global Immunoprecipitation (IP) Kit Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Immunoprecipitation (IP) Kit Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Immunoprecipitation (IP) Kit Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Immunoprecipitation (IP) Kit Market by Type
  1. 4.1 Immunoprecipitation (IP) Kit Type Introduction
  2. 4.1.1 Protein A
  3. 4.1.2 Protein G
  4. 4.2 Global Immunoprecipitation (IP) Kit Sales Volume by Type
  5. 4.2.1 Global Immunoprecipitation (IP) Kit Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Immunoprecipitation (IP) Kit Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Immunoprecipitation (IP) Kit Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Immunoprecipitation (IP) Kit Sales Value by Type
  9. 4.3.1 Global Immunoprecipitation (IP) Kit Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Immunoprecipitation (IP) Kit Sales Value by Type (2021-2032)
  11. 4.3.3 Global Immunoprecipitation (IP) Kit Sales Value Share by Type (2021-2032)
5 Immunoprecipitation (IP) Kit Market by Application
  1. 5.1 Immunoprecipitation (IP) Kit Application Introduction
  2. 5.1.1 Pharmaceuticals and Biotechnology
  3. 5.1.2 Hospital and Diagnostic Laboratory
  4. 5.1.3 Research Institute
  5. 5.1.4 Other
  6. 5.2 Global Immunoprecipitation (IP) Kit Sales Volume by Application
  7. 5.2.1 Global Immunoprecipitation (IP) Kit Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Immunoprecipitation (IP) Kit Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Immunoprecipitation (IP) Kit Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Immunoprecipitation (IP) Kit Sales Value by Application
  11. 5.3.1 Global Immunoprecipitation (IP) Kit Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Immunoprecipitation (IP) Kit Sales Value by Application (2021-2032)
  13. 5.3.3 Global Immunoprecipitation (IP) Kit Sales Value Share by Application (2021-2032)
6 Immunoprecipitation (IP) Kit Regional Sales and Value Analysis
  1. 6.1 Global Immunoprecipitation (IP) Kit Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Immunoprecipitation (IP) Kit Sales by Region (2021-2032)
  3. 6.2.1 Global Immunoprecipitation (IP) Kit Sales by Region: 2021-2026
  4. 6.2.2 Global Immunoprecipitation (IP) Kit Sales by Region (2027-2032)
  5. 6.3 Global Immunoprecipitation (IP) Kit Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Immunoprecipitation (IP) Kit Sales Value by Region (2021-2032)
  7. 6.4.1 Global Immunoprecipitation (IP) Kit Sales Value by Region: 2021-2026
  8. 6.4.2 Global Immunoprecipitation (IP) Kit Sales Value by Region (2027-2032)
  9. 6.5 Global Immunoprecipitation (IP) Kit Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Immunoprecipitation (IP) Kit Sales Value (2021-2032)
  12. 6.6.2 North America Immunoprecipitation (IP) Kit Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Immunoprecipitation (IP) Kit Sales Value (2021-2032)
  15. 6.7.2 Europe Immunoprecipitation (IP) Kit Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Immunoprecipitation (IP) Kit Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Immunoprecipitation (IP) Kit Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Immunoprecipitation (IP) Kit Sales Value (2021-2032)
  21. 6.9.2 South America Immunoprecipitation (IP) Kit Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Immunoprecipitation (IP) Kit Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Immunoprecipitation (IP) Kit Sales Value Share by Country, 2025 VS 2032
7 Immunoprecipitation (IP) Kit Country-level Sales and Value Analysis
  1. 7.1 Global Immunoprecipitation (IP) Kit Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Immunoprecipitation (IP) Kit Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Immunoprecipitation (IP) Kit Sales by Country (2021-2032)
  4. 7.3.1 Global Immunoprecipitation (IP) Kit Sales by Country (2021-2026)
  5. 7.3.2 Global Immunoprecipitation (IP) Kit Sales by Country (2027-2032)
  6. 7.4 Global Immunoprecipitation (IP) Kit Sales Value by Country (2021-2032)
  7. 7.4.1 Global Immunoprecipitation (IP) Kit Sales Value by Country (2021-2026)
  8. 7.4.2 Global Immunoprecipitation (IP) Kit Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Immunoprecipitation (IP) Kit Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Immunoprecipitation (IP) Kit Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Immunoprecipitation (IP) Kit Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbkine Scientific Co., Ltd.
  2. 8.1.1 Abbkine Scientific Co., Ltd. Company Information
  3. 8.1.2 Abbkine Scientific Co., Ltd. Business Overview
  4. 8.1.3 Abbkine Scientific Co., Ltd. Immunoprecipitation (IP) Kit Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbkine Scientific Co., Ltd. Immunoprecipitation (IP) Kit Product Portfolio
  6. 8.1.5 Abbkine Scientific Co., Ltd. Recent Developments
  7. 8.2 Active Motif
  8. 8.2.1 Active Motif Company Information
  9. 8.2.2 Active Motif Business Overview
  10. 8.2.3 Active Motif Immunoprecipitation (IP) Kit Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Active Motif Immunoprecipitation (IP) Kit Product Portfolio
  12. 8.2.5 Active Motif Recent Developments
  13. 8.3 CD Bioparticles
  14. 8.3.1 CD Bioparticles Company Information
  15. 8.3.2 CD Bioparticles Business Overview
  16. 8.3.3 CD Bioparticles Immunoprecipitation (IP) Kit Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 CD Bioparticles Immunoprecipitation (IP) Kit Product Portfolio
  18. 8.3.5 CD Bioparticles Recent Developments
  19. 8.4 Cell Signaling Technology, Inc.
  20. 8.4.1 Cell Signaling Technology, Inc. Company Information
  21. 8.4.2 Cell Signaling Technology, Inc. Business Overview
  22. 8.4.3 Cell Signaling Technology, Inc. Immunoprecipitation (IP) Kit Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Cell Signaling Technology, Inc. Immunoprecipitation (IP) Kit Product Portfolio
  24. 8.4.5 Cell Signaling Technology, Inc. Recent Developments
  25. 8.5 Engibody Biotechnology, Inc.
  26. 8.5.1 Engibody Biotechnology, Inc. Company Information
  27. 8.5.2 Engibody Biotechnology, Inc. Business Overview
  28. 8.5.3 Engibody Biotechnology, Inc. Immunoprecipitation (IP) Kit Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Engibody Biotechnology, Inc. Immunoprecipitation (IP) Kit Product Portfolio
  30. 8.5.5 Engibody Biotechnology, Inc. Recent Developments
  31. 8.6 MyBiosource, Inc.
  32. 8.6.1 MyBiosource, Inc. Company Information
  33. 8.6.2 MyBiosource, Inc. Business Overview
  34. 8.6.3 MyBiosource, Inc. Immunoprecipitation (IP) Kit Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 MyBiosource, Inc. Immunoprecipitation (IP) Kit Product Portfolio
  36. 8.6.5 MyBiosource, Inc. Recent Developments
  37. 8.7 Novus Biologicals
  38. 8.7.1 Novus Biologicals Company Information
  39. 8.7.2 Novus Biologicals Business Overview
  40. 8.7.3 Novus Biologicals Immunoprecipitation (IP) Kit Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Novus Biologicals Immunoprecipitation (IP) Kit Product Portfolio
  42. 8.7.5 Novus Biologicals Recent Developments
  43. 8.8 Proteintech Group, Inc.
  44. 8.8.1 Proteintech Group, Inc. Company Information
  45. 8.8.2 Proteintech Group, Inc. Business Overview
  46. 8.8.3 Proteintech Group, Inc. Immunoprecipitation (IP) Kit Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Proteintech Group, Inc. Immunoprecipitation (IP) Kit Product Portfolio
  48. 8.8.5 Proteintech Group, Inc. Recent Developments
  49. 8.9 Rockland Immunochemicals, Inc.
  50. 8.9.1 Rockland Immunochemicals, Inc. Company Information
  51. 8.9.2 Rockland Immunochemicals, Inc. Business Overview
  52. 8.9.3 Rockland Immunochemicals, Inc. Immunoprecipitation (IP) Kit Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Rockland Immunochemicals, Inc. Immunoprecipitation (IP) Kit Product Portfolio
  54. 8.9.5 Rockland Immunochemicals, Inc. Recent Developments
  55. 8.10 Sino Biological, Inc.
  56. 8.10.1 Sino Biological, Inc. Company Information
  57. 8.10.2 Sino Biological, Inc. Business Overview
  58. 8.10.3 Sino Biological, Inc. Immunoprecipitation (IP) Kit Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Sino Biological, Inc. Immunoprecipitation (IP) Kit Product Portfolio
  60. 8.10.5 Sino Biological, Inc. Recent Developments
  61. 8.11 Takara Bio Inc.
  62. 8.11.1 Takara Bio Inc. Company Information
  63. 8.11.2 Takara Bio Inc. Business Overview
  64. 8.11.3 Takara Bio Inc. Immunoprecipitation (IP) Kit Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Takara Bio Inc. Immunoprecipitation (IP) Kit Product Portfolio
  66. 8.11.5 Takara Bio Inc. Recent Developments
  67. 8.12 Merck KGaA
  68. 8.12.1 Merck KGaA Company Information
  69. 8.12.2 Merck KGaA Business Overview
  70. 8.12.3 Merck KGaA Immunoprecipitation (IP) Kit Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Merck KGaA Immunoprecipitation (IP) Kit Product Portfolio
  72. 8.12.5 Merck KGaA Recent Developments
  73. 8.13 ACE Biotechnology
  74. 8.13.1 ACE Biotechnology Company Information
  75. 8.13.2 ACE Biotechnology Business Overview
  76. 8.13.3 ACE Biotechnology Immunoprecipitation (IP) Kit Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 ACE Biotechnology Immunoprecipitation (IP) Kit Product Portfolio
  78. 8.13.5 ACE Biotechnology Recent Developments
  79. 8.14 Thermo Fisher Scientific (China) Co., Ltd.
  80. 8.14.1 Thermo Fisher Scientific (China) Co., Ltd. Company Information
  81. 8.14.2 Thermo Fisher Scientific (China) Co., Ltd. Business Overview
  82. 8.14.3 Thermo Fisher Scientific (China) Co., Ltd. Immunoprecipitation (IP) Kit Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Thermo Fisher Scientific (China) Co., Ltd. Immunoprecipitation (IP) Kit Product Portfolio
  84. 8.14.5 Thermo Fisher Scientific (China) Co., Ltd. Recent Developments
  85. 8.15 Beyotime Biotech. Inc.
  86. 8.15.1 Beyotime Biotech. Inc. Company Information
  87. 8.15.2 Beyotime Biotech. Inc. Business Overview
  88. 8.15.3 Beyotime Biotech. Inc. Immunoprecipitation (IP) Kit Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Beyotime Biotech. Inc. Immunoprecipitation (IP) Kit Product Portfolio
  90. 8.15.5 Beyotime Biotech. Inc. Recent Developments
  91. 8.16 Shanghai Epizyme Biomedical Technology Co., Ltd
  92. 8.16.1 Shanghai Epizyme Biomedical Technology Co., Ltd Company Information
  93. 8.16.2 Shanghai Epizyme Biomedical Technology Co., Ltd Business Overview
  94. 8.16.3 Shanghai Epizyme Biomedical Technology Co., Ltd Immunoprecipitation (IP) Kit Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Shanghai Epizyme Biomedical Technology Co., Ltd Immunoprecipitation (IP) Kit Product Portfolio
  96. 8.16.5 Shanghai Epizyme Biomedical Technology Co., Ltd Recent Developments
  97. 8.17 Beaver
  98. 8.17.1 Beaver Company Information
  99. 8.17.2 Beaver Business Overview
  100. 8.17.3 Beaver Immunoprecipitation (IP) Kit Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Beaver Immunoprecipitation (IP) Kit Product Portfolio
  102. 8.17.5 Beaver Recent Developments
  103. 8.18 Wuhan Dia-An Biotechnology Co., Ltd
  104. 8.18.1 Wuhan Dia-An Biotechnology Co., Ltd Company Information
  105. 8.18.2 Wuhan Dia-An Biotechnology Co., Ltd Business Overview
  106. 8.18.3 Wuhan Dia-An Biotechnology Co., Ltd Immunoprecipitation (IP) Kit Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Wuhan Dia-An Biotechnology Co., Ltd Immunoprecipitation (IP) Kit Product Portfolio
  108. 8.18.5 Wuhan Dia-An Biotechnology Co., Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Immunoprecipitation (IP) Kit Value Chain Analysis
  2. 9.1.1 Immunoprecipitation (IP) Kit Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Immunoprecipitation (IP) Kit Sales Mode & Process
  6. 9.2 Immunoprecipitation (IP) Kit Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Immunoprecipitation (IP) Kit Distributors
  9. 9.2.3 Immunoprecipitation (IP) Kit Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst